Saturday, July 11, 2026

Patent directory · USPTO A61K / A61P

Patents matching “inhibitor”

2,878 pharma patents match "inhibitor" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,878
Index total 30,257
Page 85 / 120

Quick answer

This filtered view shows 2,878 pharmaceutical patents matching "inhibitor" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,878 results for “inhibitor” · 30,257 patents in full index Clear search

  1. US 8399425

    Alleviating neuropathic pain with EETs and sEH inhibitors

    The Regents of the University of California · Granted Mar 19, 2013 · Expires Mar 14, 2033

    granted
  2. US 8394788

    Phenylsulfoxyoxazole compound inhibitors of urea transporters

    The Regents of the University of California · Granted Mar 12, 2013 · Expires Mar 7, 2033

    granted
  3. US 8394803

    Gyrase inhibitors and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Mar 12, 2013 · Expires Mar 7, 2033

    granted
  4. US 8394951

    Protein kinase C inhibitors and uses thereof

    Rigel Pharmaceuticals, Inc. · Granted Mar 12, 2013 · Expires Mar 7, 2033

    granted
  5. US 8394952

    Dihydrodiazepines useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Mar 12, 2013 · Expires Mar 7, 2033

    granted
  6. US 8389557

    Triazole derivatives useful as Axl inhibitors

    Rigel Pharmaceuticals, Inc. · Granted Mar 5, 2013 · Expires Feb 28, 2033

    granted
  7. US 8389731

    Chiral pyrrolidine core compounds en route to inhibitors of nitric oxide synthase

    Northwestern University · Granted Mar 5, 2013 · Expires Feb 28, 2033

    granted
  8. US 8389734

    Amides useful as inhibitors of voltage-gated sodium channels

    Vertex Pharmaceuticals Incorporated · Granted Mar 5, 2013 · Expires Feb 28, 2033

    granted
  9. US 8383583

    Macrocyclic, pyridazinone-containing hepatitis C serine protease inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Feb 26, 2013 · Expires Feb 21, 2033

    granted
  10. US 8383633

    Aminopyrimidines useful as kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Feb 26, 2013 · Expires Feb 21, 2033

    granted
  11. US 8377872

    Cyclic P3 tripeptide hepatitis C serine protease inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Feb 19, 2013 · Expires Feb 14, 2033

    granted
  12. US 8377924

    Protein kinase C inhibitors and uses thereof

    Rigel Pharmaceuticals, Inc. · Granted Feb 19, 2013 · Expires Feb 14, 2033

    granted
  13. US 8377945

    Small molecule inhibitors of spleen tyrosine kinase (SYK)

    Rigel Pharmaceuticals, Inc. · Granted Feb 19, 2013 · Expires Feb 14, 2033

    granted
  14. US 8377926

    Aminopyridine kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Feb 19, 2013 · Expires Feb 14, 2033

    granted
  15. US 8372802

    Fluorinated macrocyclic compounds as hepatitis C virus inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Feb 12, 2013 · Expires Feb 7, 2033

    granted
  16. US 8372835

    Pyrrolopyrazines and pyrazolopyrazines useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Feb 12, 2013 · Expires Feb 7, 2033

    granted
  17. US 8372850

    Aminopyridines and aminopyrimidines useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Feb 12, 2013 · Expires Feb 7, 2033

    granted
  18. US 8372873

    Inhibitors of serine proteases

    Vertex Pharmaceuticals Incorporated · Granted Feb 12, 2013 · Expires Feb 7, 2033

    granted
  19. US 8367690

    Aminopyridine derivatives having aurora a selective inhibitory action

    Vertex Pharmaceuticals Incorporated · Granted Feb 5, 2013 · Expires Jan 31, 2033

    granted
  20. US 8367697

    Kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Feb 5, 2013 · Expires Jan 31, 2033

    granted
  21. US 8361958

    Oximyl HCV serine protease inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Jan 29, 2013 · Expires Jan 24, 2033

    granted
  22. US 8362043

    Caspase inhibitors and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Jan 29, 2013 · Expires Jan 24, 2033

    granted
  23. US 8354538

    Small-molecule inhibitors of the androgen receptor

    The Regents of the University of California · Granted Jan 15, 2013 · Expires Jan 10, 2033

    granted
  24. US 8349333

    Allergy inhibitor compositions and kits and methods of using the same

    China Agricultural University · Granted Jan 8, 2013 · Expires Jan 3, 2033

    granted